Compare TECH & LI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TECH | LI |
|---|---|---|
| Founded | 1976 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 12.5B |
| IPO Year | 1995 | 2019 |
| Metric | TECH | LI |
|---|---|---|
| Price | $72.61 | $11.51 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 10 |
| Target Price | ★ $71.82 | $19.66 |
| AVG Volume (30 Days) | 2.6M | ★ 2.6M |
| Earning Date | 05-06-2026 | 05-28-2026 |
| Dividend Yield | ★ 0.62% | N/A |
| EPS Growth | ★ 152.17 | N/A |
| EPS | ★ 1.16 | N/A |
| Revenue | ★ $1,215,039,000.00 | N/A |
| Revenue This Year | $2.49 | $18.98 |
| Revenue Next Year | $6.40 | $22.72 |
| P/E Ratio | $62.56 | ★ $29.50 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $43.20 | $11.44 |
| 52 Week High | $72.69 | $26.50 |
| Indicator | TECH | LI |
|---|---|---|
| Relative Strength Index (RSI) | 64.86 | 40.95 |
| Support Level | $72.11 | N/A |
| Resistance Level | $72.62 | $12.56 |
| Average True Range (ATR) | 0.17 | 0.26 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 86.07 | 5.77 |
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Li Auto is one of China's leading new energy vehicle manufacturers. Founded in 2015, the company designs, develops, manufactures, and sells premium smart NEVs with a particular focus on family size premium SUVs and MPVs. Li Auto started volume production of its first model—the Li One, an SUV that is a premium plug-in electric vehicle- in November 2019. Besides PHEVs, its product portfolio now extends to EVs that are fully battery-powered, reaching a wide audience. It has sold over 400,000 NEVs in 2025, accounting for about 3% of China's passenger NEV market.